Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues ...

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. American Well Corporation (AMWL) is a stock that can certainly grab the attention of ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best cheap biotech stocks to buy now. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported record fiscal Q4 and record full year 2025 ...

MXene nanosheet-based catalytic membranes efficiently degrade antibiotics in pharmaceutical wastewater while reducing ...

Shares of Catalyst Pharmaceutical (CPRX) have gained 1.7% over the past four weeks to close the last trading session at $24.32, but there could still be a solid upside left in the stock if short-term ...

Alumis Inc. upgraded to Buy on strong Phase 3 psoriasis data for envudeucitinib, NDA plans, and upside valuation. Click here ...

Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...

On February 17, 2026, Superstring Capital Management reported selling 345,869 shares of Terns Pharmaceuticals (TERN 1.14%) in ...

The next 10 months might be challenging for this biotech.